Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Prefilled Liquid Etanercept (Yisaipu) in Ankylosing Spondylitis
NCT04345458Phase 3Completed
- Sponsor
- 3S Guojian Pharmaceutical
- Start
- Mar 2014
- Primary completion
- Jul 2015
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 3 trial of etanercept in ankylosing spondylitis (AS), sponsored by 3S Guojian Pharmaceutical. Started Mar 2014; status: completed.
02
Drugs
etanercept
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on NCT04345458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04345458.